Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02440685
Title A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Asana BioSciences
Indications

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

lymphoma

myelofibrosis

Advanced Solid Tumor

chronic lymphocytic leukemia

peripheral T-cell lymphoma

Therapies

ASN002

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.